Lombard Odier Asset Management USA Corp Makes New $393,000 Investment in Omnicell, Inc. $OMCL

Lombard Odier Asset Management USA Corp purchased a new position in Omnicell, Inc. (NASDAQ:OMCL) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 13,362 shares of the company’s stock, valued at approximately $393,000.

A number of other large investors have also made changes to their positions in the stock. Sumitomo Mitsui Trust Group Inc. increased its position in Omnicell by 1.3% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,423,604 shares of the company’s stock worth $41,854,000 after purchasing an additional 17,680 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Omnicell by 2.6% during the 2nd quarter. Geode Capital Management LLC now owns 1,195,896 shares of the company’s stock worth $35,163,000 after purchasing an additional 30,678 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Omnicell by 52.6% during the 1st quarter. Wellington Management Group LLP now owns 496,680 shares of the company’s stock worth $17,364,000 after purchasing an additional 171,116 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Omnicell by 1.7% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 461,506 shares of the company’s stock worth $13,568,000 after buying an additional 7,518 shares in the last quarter. Finally, Cubist Systematic Strategies LLC raised its position in shares of Omnicell by 56.8% in the first quarter. Cubist Systematic Strategies LLC now owns 274,489 shares of the company’s stock valued at $9,596,000 after buying an additional 99,406 shares during the last quarter. Institutional investors and hedge funds own 97.70% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Omnicell in a research report on Wednesday, October 8th. Benchmark raised their price objective on Omnicell from $45.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Omnicell currently has an average rating of “Hold” and an average target price of $43.00.

Omnicell Trading Down 0.1%

Shares of OMCL opened at $43.49 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.21 and a current ratio of 1.44. Omnicell, Inc. has a one year low of $22.66 and a one year high of $47.70. The stock has a 50-day moving average price of $33.99 and a 200 day moving average price of $31.68. The company has a market capitalization of $1.95 billion, a P/E ratio of 101.14, a P/E/G ratio of 5.39 and a beta of 0.83.

Insiders Place Their Bets

In other Omnicell news, EVP Corey J. Manley sold 3,880 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $33.25, for a total transaction of $129,010.00. Following the sale, the executive vice president owned 110,653 shares in the company, valued at $3,679,212.25. This represents a 3.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.52% of the stock is currently owned by corporate insiders.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.